152 related articles for article (PubMed ID: 19815638)
1. Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma.
Sheu JJ; Lee CH; Ko JY; Tsao GS; Wu CC; Fang CY; Tsai FJ; Hua CH; Chen CL; Chen JY
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2709-16. PubMed ID: 19815638
[TBL] [Abstract][Full Text] [Related]
2. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
3. Characterization of 3p, 5p, and 3q in two nasopharyngeal carcinoma cell lines, using region-specific multiplex fluorescence in situ hybridization probes.
Tjia WM; Sham JS; Hu L; Tai AL; Guan XY
Cancer Genet Cytogenet; 2005 Apr; 158(1):61-6. PubMed ID: 15771906
[TBL] [Abstract][Full Text] [Related]
4. Amplicons on chromosome 3 contain oncogenes induced by recurrent exposure to 12-O-tetradecanoylphorbol-13-acetate and sodium n-butyrate and Epstein-Barr virus reactivation in a nasopharyngeal carcinoma cell line.
Lee CH; Fang CY; Sheu JJ; Chang Y; Takada K; Chen JY
Cancer Genet Cytogenet; 2008 Aug; 185(1):1-10. PubMed ID: 18656687
[TBL] [Abstract][Full Text] [Related]
5. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
6. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
[TBL] [Abstract][Full Text] [Related]
7. Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines.
Or YY; Hui AB; Tam KY; Huang DP; Lo KW
Int J Oncol; 2005 Jan; 26(1):49-56. PubMed ID: 15586224
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.
Zhou Y; Zeng Z; Zhang W; Xiong W; Li X; Zhang B; Yi W; Xiao L; Wu M; Shen S; Li X; Cao L; Tang K; Li G
Eur J Cancer Prev; 2008 Nov; 17(6):561-71. PubMed ID: 18941378
[TBL] [Abstract][Full Text] [Related]
9. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
[TBL] [Abstract][Full Text] [Related]
12. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
[TBL] [Abstract][Full Text] [Related]
13. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
Yao J; Weremowicz S; Feng B; Gentleman RC; Marks JR; Gelman R; Brennan C; Polyak K
Cancer Res; 2006 Apr; 66(8):4065-78. PubMed ID: 16618726
[TBL] [Abstract][Full Text] [Related]
14. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.
Hurst CD; Fiegler H; Carr P; Williams S; Carter NP; Knowles MA
Oncogene; 2004 Mar; 23(12):2250-63. PubMed ID: 14968109
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.
Singh B; Gogineni SK; Sacks PG; Shaha AR; Shah JP; Stoffel A; Rao PH
Cancer Res; 2001 Jun; 61(11):4506-13. PubMed ID: 11389082
[TBL] [Abstract][Full Text] [Related]
16. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
[TBL] [Abstract][Full Text] [Related]
17. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.
Olejniczak ET; Van Sant C; Anderson MG; Wang G; Tahir SK; Sauter G; Lesniewski R; Semizarov D
Mol Cancer Res; 2007 Apr; 5(4):331-9. PubMed ID: 17426248
[TBL] [Abstract][Full Text] [Related]
18. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
[TBL] [Abstract][Full Text] [Related]
19. [Molecular genetic progression on nasopharyngeal carcinoma].
Shao JY; Zeng WF; Zeng YX
Ai Zheng; 2002 Jan; 21(1):1-10. PubMed ID: 12500388
[TBL] [Abstract][Full Text] [Related]
20. Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.
Jung V; Kindich R; Kamradt J; Jung M; Müller M; Schulz WA; Engers R; Unteregger G; Stöckle M; Zimmermann R; Wullich B
Mol Cancer Res; 2006 Mar; 4(3):169-76. PubMed ID: 16547154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
